{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:35:00Z","timestamp":1757702100435},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.nucmedbio.2005.07.006","type":"journal-article","created":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T07:24:07Z","timestamp":1130311447000},"page":"845-850","source":"Crossref","is-referenced-by-count":8,"title":["Distribution and pharmacokinetic analysis of angiostatin radioiodine labeled with high stability"],"prefix":"10.1016","volume":"32","author":[{"given":"Sung Hee","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Ho","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Young","family":"Paik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bong-Ho","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon-Sang","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yearn Seong","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2005.07.006_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma","volume":"79","author":"O'Reilly","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nm0696-689","article-title":"Angiostatin induces and sustains dormancy of human primary tumors in mice","volume":"2","author":"O'Reilly","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib3","series-title":"Pharmacokinetics in drug discovery and development","author":"Schoenwald","year":"2002"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib4","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/S0959-8049(02)00413-6","article-title":"PET for in vivo pharmacokinetic and pharmacodynamic measurements","volume":"38","author":"Gupta","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S1076-6332(00)80671-6","article-title":"Molecular imaging in cancer: future directions and goals of the National Cancer Institute","volume":"7","author":"Hoffman","year":"2000","journal-title":"Acad Radiol"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00259-002-0783-8","article-title":"Tumour angiogenesis pathways: related clinical issues and implications for nuclear medicine imaging","volume":"29","author":"Van De Wiele","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0215(20010101)91:1<1::AID-IJC1001>3.0.CO;2-5","article-title":"Pharmacokinetics and whole body distribution of elastase derived angiostatin (K1-3) in rats","volume":"91","author":"Molema","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib8","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s00259-002-1094-9","article-title":"Specific endothelial binding and tumor uptake of radiolabeled angiostatin","volume":"30","author":"Lee","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib9","first-page":"111","article-title":"Pharmacokinetic considerations in the development of peptide-based imaging agents","volume":"41","author":"Lister-James","year":"1997","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib10","first-page":"463","article-title":"Radiolabeled interleukin-8: specific scintigraphic detection of infection within a few hours","volume":"41","author":"Van der Laken","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib11","first-page":"671","article-title":"Iodination of annexin V for imaging apoptosis","volume":"43","author":"Russell","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ijc.10674","article-title":"Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins","volume":"102","author":"Halin","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib13","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJM198110083051508","article-title":"Angiogenesis and neoplasia","volume":"305","author":"Gullino","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib14","first-page":"1446","article-title":"Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate","volume":"48","author":"Zalutsky","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib15","first-page":"1761","article-title":"Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastasis after partial hepatectomy","volume":"60","author":"Drixler","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib16","first-page":"4025","article-title":"Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study","volume":"9","author":"Beerepoot","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib17","first-page":"3a","article-title":"Recombinant human angiostatin (rhA): a phase I clinical trial assessing safety, pharmacokinetics and pharmacodynamics","volume":"20","author":"De Moraes","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib18","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1073\/pnas.96.6.2811","article-title":"Angiostatin binds ATP synthase on the surface of human endothelial cells","volume":"96","author":"Moser","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1021\/bc00034a020","article-title":"Catabolism of radioiodinated murine monoclonal antibody f(ab\u2032)2 fragment labeled using N-succinimidyl 3-iodobenzoate and Iodogen methods","volume":"6","author":"Garg","year":"1995","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2005.07.006_bib20","first-page":"2276","article-title":"Enhanced tumor specificity of 741F8-1 (sFv\u2032)2, an anti-c-erbB-2 single-chain Fv dimmer, mediated by stable radioiodine conjugation","volume":"36","author":"Adams","year":"1995","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805105001964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805105001964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T10:21:00Z","timestamp":1548066060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805105001964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0969805105001964"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2005.07.006","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}